Impact of reference category and number of traits in the cluster on risk of coronary heart disease in metabolic syndrome: Prospective data from the bruneck study

Metabolic Syndrome and Related Disorders

Volumn 9, Issue 4, 2011, Pages 313-318

  Bonora, Enzo ^a,b   Kiechl, Stefan ^c   Zoppini, Giacomo ^a,b   Targher, Giovanni ^a,b   Meigs, James B ^d   Willeit, Johann ^c   Oberhollenzer, Friedrich ^e   Bonadonna, Riccardo C ^a,b   Muggeo, Michele ^a,b  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

^c UNIVERSITY OF INNSBRUCK   (Austria)

^d HARVARD MEDICAL SCHOOL   (United States)

^e BRUNECK HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CARDIOVASCULAR RISK; CLINICAL FEATURE; CLUSTER ANALYSIS; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HUMAN; ISCHEMIC HEART DISEASE; ITALY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POPULATION RESEARCH; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; REVIEW;

ADULT; AGE FACTORS; AGED; CHOLESTEROL, LDL; CORONARY DISEASE; FEMALE; HUMANS; ITALY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SMOKING;

EID: 79960818604     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2010.0130     Document Type: Review

References (34)

1. Kylin E. Studien ueber das Hypertonie-Hyperglykamie-Hyperurikamiesyndrom. Zentralblatt fuer Innere Medizin 1923;44:105-127.
2. Avogaro P, Crepaldi G, Enzi G, Tiengo A. Associazione di iperlipemia, diabete mellito e obesitàdi medio grado. Acta Diabetol Lat 1967;4:572-590.
3. Reaven GM. Banting lecture. Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607. (Pubitemid 19004941)
4. WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Geneva, Switzerland: World Health Organization; Publication 1999; WHO/NCD/NCS/99.2.
5. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
6. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr. International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-1645.
7. Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, Van Pelt RE, Hong Wang, Eckel RH. The metabolic syndrome. Endocr Rev 2008;29:777-822.
8. Ford ES, Giles W, Dietz WH. Prevalence of the metabolic syndrome among US adults. JAMA 2002;287:356-359.
9. Balkau B, Charles MA, Drivsholm T, Borch-Johnsen K, Wareham N, Yudkin JS, Morris R, Zavaroni I, van Dam R, Feskins E, Gabriel R, Diet M, Nilsson P, Hedblad B; European Group For The Study Of Insulin Resistance (EGIR). Frequency of the WHO metabolic syndrome in European cohorts, and al alternative definition of an insulin resistance syndrome. Diabetes Metab 2002;28:364-376. (Pubitemid 35434310)
10. Meigs JB, Wilson PWF, Nathan DM, D'Agostino RB Sr, Williams K, Haffner SM. Prevalence and characteristics of the Metabolic Syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes 2003;52:2160-2167. (Pubitemid 36919812)
11. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Bonadonna RC, Muggeo M: Bruneck Study. The metabolic syndrome: Epidemiology and more extensive phenotypic description. Cross-sectional data from the Bruneck Study. Int J Obes 2003;27:1283-1289. (Pubitemid 37281677)
12. Imperatore G, Riccardi G, Iovine C, Rivellese AA, Vaccaro O. Plasma fibrinogen: A new factor of the metabolic syndrome. Diabetes Care 1998;21:649-654. (Pubitemid 28172950)
13. Festa A, D'Agostino R Jr, Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome. The Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000;102:42-47. (Pubitemid 30430551)
14. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, NissénM, Taskinen MR, Groop L. Cardiovascular morbidity and mortality associated with metabolic syndrome. Diabetes Care 2001;24:683-689. (Pubitemid 32893993)
15. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. The metabolic syndrome and total and cardiovascular disease mortality in middleaged men. JAMA 2002;288:2709-2716. (Pubitemid 35403784)
16. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Bonadonna RC, Muggeo M; Bruneck Study. Carotid atherosclerosis and coronary heart disease in the metabolic syndrome. Prospective data from the Bruneck Study. Diabetes Care 2003;26:1251-1257. (Pubitemid 36929281)
17. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K; DECODE Study Group. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic european men and women. Arch Intern Med 2004;164:1066-1076. (Pubitemid 38668985)
18. Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP. National cholesterol education program versus World Health Organization metabolic syndrome in relation to allcause and cardiovascular mortality in the San Antonio HeartStudy. Circulation 2004;110:1251-1257.
19. Dekker JM, Girman C, Rhodes T, Nijpels G, Stehouwer CD, Bouter LM, Heine RJ. Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation 2005;112:666-673. (Pubitemid 41099045)
20. Reaven GM. The metabolic syndrome: requiescat in pace. Clin Chem 2005;51:931-938. (Pubitemid 40740871)
21. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: Time for a critical appraisal. Diabetes Care 2005;28: 2289-2304.
22. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: A summary of the evidence. Diabetes Care 2005;28:1769-1778. (Pubitemid 40923091)
23. Willeit J, Kiechl S. Prevalence and risk factors of asymptomatic extra-cranial carotid artery atherosclerosis. A population- based study. Arterioscl Thromb 1993;13:661-668. (Pubitemid 23141754)
24. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G, Alberiche M, Bonadonna RC, Muggeo M. Prevalence of insulin resistance in metabolic disorders. The Bruneck Study. Diabetes 1998;47:1643-1649. (Pubitemid 28445355)
25. Kiechl S, Lorenz E, Reindl M, Wiedermann CJ, OberhollenzerF, Bonora E, Willeit J, Schwartz DA. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 2002; 347:185-192. (Pubitemid 34764822)
26. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Meigs JB, Bonadonna RC, Muggeo M; Bruneck study. Population- based incidence rates and risk factors for type 2 diabetes in white individuals: The Bruneck Study. Diabetes 2004;53:1782-1789. (Pubitemid 38857036)
27. Friedewald WT, Levy RJ, Fredrickson DS. Estimation of the concentration of low-density-lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
28. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419. (Pubitemid 15018832)
29. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: Studies in subjects with various degree of glucose tolerance and insulin sensitivity. Diabetes Care 2000;23:57-63. (Pubitemid 30022895)
30. IHD register Report of the Fifth Working Group. Copenhagen, Denmark; 1971.
31. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, Williams GR. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004;110:1245-1250. (Pubitemid 39202340)
32. Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, Haffner SM, Isles C, Macfarlane PW, Packard CJ, Cobbe SM, Shepherd J. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the west of Scotland coronary prevention study. Circulation 2003;108:414-419. (Pubitemid 36935533)
33. McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE, Ballantyne CM, Heiss G. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities Study. Diabetes Care 2005;28:385-390. (Pubitemid 40170944)
34. Wilson PWF, D'Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular diseaseand type 2 diabetes mellitus. Circulation 2005;112:3066-3072. (Pubitemid 43113437)